Evidence map›Paper›PMID 37851080›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment.

Eileen S Carpenter, Padma Kadiyala, Ahmed M Elhossiny, Samantha B Kemp, Jay Li, Nina G Steele, Rémy Nicolle, Zeribe C Nwosu, Julia Freeman, Henry Dai and 36 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Single-cell multi-omics in the study of digestive system cancers.Computational and structural biotechnology journal · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 2 institutions in 2 countries.

Eileen S CarpenterDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6775-6943
Padma KadiyalaImmunology Graduate Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-3273-9905
Ahmed M ElhossinyDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0884-8754
Samantha B KempDepartment of Molecular and Cellular Pathology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-1505-4015
Jay LiMedical Scientist Training Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8146-4450
Nina G SteeleDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1564-3562
Rémy NicolleUniversité Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, Paris, France.ORCID 0000-0001-8084-1173
Zeribe C NwosuDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1641-2045
Julia FreemanDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0003-0623-8212
Henry DaiDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0001-3006-0405
Daniel PagliaDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0001-2875-1776
Wenting DuDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6765-0129
Katelyn DonahueCancer Biology Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9535-9275
Jacqueline MoralesCancer Biology Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4086-9213
Paola I Medina-CabreraCancer Biology Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8034-9979
Monica E BonillaCancer Biology Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-1936-3712
Lindsey HarrisDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5890-9546
Stephanie TheDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-6660-4136
Valerie GunchickDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9392-0644
Nicole PetersonDepartment of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0000-6035-4124
Kristee BrownDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5123-4945
Michael MatteaDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0006-6144-7668
Carlos E EspinozaDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0000-0460-1514
Jake McGueDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6131-7798
Sarah M KabalaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0005-0432-1893
Rachel K BaliiraCancer Biology Program, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-2403-2173
Nur M RenolletDepartment of Surgery, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0000-4668-8806
Ayden G MooneyDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0009-4069-2500
Jianhua LiuDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-3585-6557
Sean BhallaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-5865-6948
Jeremy P FaridaDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0007-2569-2364
Christopher KoDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-6004-1558
Jorge D MachicadoDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-2065-1367
Richard S KwonDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-4652-1106
Erik-Jan WamstekerDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0009-0007-6689-1204
Allison SchulmanDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-3913-8045
Michelle A AndersonDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-8416-4218
Ryan LawDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-7048-9268
Anoop PrabhuDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0617-8224
Pierre A CoulombeDepartment of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-0680-2373
Arvind RaoRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9613-426X
Timothy L FrankelRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5987-0404
Filip BednarRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5193-9817
Jiaqi ShiRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-4893-1587
Vaibhav SahaiRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0003-1892-1548
Marina Pasca Di MaglianoRogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9632-9035
University of Michigan · USCentre National de la Recherche Scientifique · FR

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVID P OLSON · 2013 to 2026
$24.3M
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic CancerP50CA221707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT · 2019 to 2023
$11.0M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic CancerU54CA274371 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Elana Fertig · 2022 to 2026
$9.5M
Fibroblast orchestration of the immune response in pancreatic cancerU01CA274154 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Howard C. Crawford, Timothy Louis Frankel · 2022 to 2026
$4.2M
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade GliomasR37CA214955 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KURTEK, SEBASTIAN, RAO, ARVIND · 2018 to 2024
$3.9M
Proteogenomics of Cancer Training ProgramT32CA140044 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, ARVIND, SARTOR, MAUREEN AGNES · 2010 to 2024
$3.9M
Training in Basic and Translational Digestive SciencesT32DK094775 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHN Y KAO, LINDA C. SAMUELSON · 2012 to 2026
$3.6M
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironmentR01CA260752 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PASCA DI MAGLIANO, MARINA · 2022 to 2025
$2.8M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Dissecting the role of Notch signaling in the pancreatic cancer microenvironment.R01CA271510 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Filip Bednar, Marina Pasca Di Magliano · 2022 to 2026
$2.6M
BLRD VA IK2 BX005875Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) T32-DK094775National Cancer Institute (NCI) K08CA201581National Cancer Institute (NCI) K08-CA234222National Cancer Institute (NCI) P30-CA046592National Cancer Institute (NCI) R01-CA260752National Cancer Institute (NCI) R01-CA264843National Cancer Institute (NCI) R01-CA268426National Cancer Institute (NCI) R01-CA271510National Cancer Institute (NCI) R01-CA275182National Cancer Institute (NCI) R37CA214955National Cancer Institute (NCI) R37-CA262209National Cancer Institute (NCI) U01-CA274154National Cancer Institute (NCI) U54-CA274371National Institute of Allergy and Infectious Diseases (NIAID) T32-AI007413National Institute of Biomedical Imaging and Bioengineering (NIBIB) R21-EB026089NCI NIH HHS K08 CA201581NCI NIH HHS K08 CA234222NCI NIH HHS K99 CA267176NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA221707NCI NIH HHS R01 CA260752NCI NIH HHS R01 CA264843NCI NIH HHS R01 CA268426NCI NIH HHS R01 CA271510NCI NIH HHS R01 CA275182NCI NIH HHS R37 CA214955NCI NIH HHS R37 CA262209NCI NIH HHS T32 CA140044NCI NIH HHS U01 CA224145NCI NIH HHS U01 CA274154NCI NIH HHS U54 CA274371NIAID NIH HHS T32 AI007413NIBIB NIH HHS R21 EB026089NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK128102NIDDK NIH HHS T32 DK094775NIGMS NIH HHS T32 GM145304U.S. Department of Veterans Affairs (VA) IK2BX005875
6 · The paper itself

Abstract

purposePancreatic ductal adenocarcinoma (PDAC) is generally divided in two subtypes, classical and basal. Recently, single-cell RNA sequencing has uncovered the coexistence of basal and classical cancer cells, as well as intermediary cancer cells, in individual tumors. The latter remains poorly understood; here, we sought to characterize them using a multimodal approach. EXPERIMENTAL

designWe performed subtyping on a single-cell RNA sequencing dataset containing 18 human PDAC samples to identify multiple intermediary subtypes. We generated patient-derived PDAC organoids for functional studies. We compared single-cell profiling of matched blood and tumor samples to measure changes in the local and systemic immune microenvironment. We then leveraged longitudinally patient-matched blood to follow individual patients over the course of chemotherapy.

resultsWe identified a cluster of KRT17-high intermediary cancer cells that uniquely express high levels of CXCL8 and other cytokines. The proportion of KRT17high/CXCL8+ cells in patient tumors correlated with intratumoral myeloid abundance, and, interestingly, high protumor peripheral blood granulocytes, implicating local and systemic roles. Patient-derived organoids maintained KRT17high/CXCL8+ cells and induced myeloid cell migration in a CXCL8-dependent manner. In our longitudinal studies, plasma CXCL8 decreased following chemotherapy in responsive patients, while CXCL8 persistence portended worse prognosis.

conclusionsThrough single-cell analysis of PDAC samples, we identified KRT17high/CXCL8+ cancer cells as an intermediary subtype, marked by a unique cytokine profile and capable of influencing myeloid cells in the tumor microenvironment and systemically. The abundance of this cell population should be considered for patient stratification in precision immunotherapy. See related commentary by Faraoni and McAllister, p. 2297.

Indexed as

Carcinoma, Pancreatic DuctalInterleukin-8Myeloid CellsPancreatic NeoplasmsTumor MicroenvironmentBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticHumansOrganoidsSingle-Cell AnalysisBiomarkers, TumorCXCL8 protein, humanInterleukin-8

Identifiers

PMID37851080
PMCPMC11024060
OpenAlexW4387729592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.